CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Oct. 31, 2019—Fujirebio Diagnostics received FDA clearance for its Lumipulse G whole PTH Assay for testing on the Lumipulse G1200 immunoassay platform.
Pages: 1 2
Oct. 31, 2019—Fujirebio Diagnostics received FDA clearance for its Lumipulse G whole PTH Assay for testing on the Lumipulse G1200 immunoassay platform.
Tagged with: Fujirebio Diagnostics